Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors (Q72327079)
Jump to navigation
Jump to search
scientific article published on 01 February 1995
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors |
scientific article published on 01 February 1995 |
Statements
Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors (English)
G Catimel
G G Chabot
J P Guastalla
A Dumortier
C Cote
C Engel
A Gouyette
A Mathieu-Boué
M Mahjoubi
1 February 1995